Detalles de la búsqueda
1.
Ductal carcinoma in situ of the breast: finding the balance between overtreatment and undertreatment.
Lancet
; 2024 May 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-38735296
2.
21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.
N Engl J Med
; 385(25): 2336-2347, 2021 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34914339
3.
Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: final analysis of LUCY.
Breast Cancer Res Treat
; 204(2): 237-248, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38112922
4.
Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: Subgroup analyses from the phase III OlympiAD trial.
Int J Cancer
; 153(4): 803-814, 2023 08 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36971103
5.
Survival outcomes of metastatic breast cancer patients by germline BRCA1/2 status in a large multicenter real-world database.
Int J Cancer
; 152(5): 921-931, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36161271
6.
Insights adjusting for non-adherence in randomized clinical trials: a reanalysis of an adjuvant trial of tamoxifen duration in early breast cancer.
Br J Cancer
; 129(9): 1516-1523, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37697030
7.
Real-World Impact of Adjuvant Anti-HER2 Treatment on Characteristics and Outcomes of Women With HER2-Positive Metastatic Breast Cancer in the ESME Program.
Oncologist
; 28(10): e867-e876, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37589218
8.
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.
Breast Cancer Res Treat
; 199(2): 371-379, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36988749
9.
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
BMC Med
; 21(1): 87, 2023 03 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36882736
10.
Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial.
Lancet Oncol
; 23(11): 1367-1377, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36183733
11.
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Br J Cancer
; 127(11): 1963-1973, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36207609
12.
Real-Time Detection of ESR1 Mutation in Blood by Droplet Digital PCR in the PADA-1 Trial: Feasibility and Cross-Validation with NGS.
Anal Chem
; 94(16): 6297-6303, 2022 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35416669
13.
Study protocol comparing the ethical, psychological and socio-economic impact of personalised breast cancer screening to that of standard screening in the "My Personal Breast Screening" (MyPeBS) randomised clinical trial.
BMC Cancer
; 22(1): 507, 2022 May 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35524202
14.
A phase II study of TAS-117 in patients with advanced solid tumors harboring germline PTEN-inactivating mutations.
Future Oncol
; 18(30): 3377-3387, 2022 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-36039910
15.
BEAUTY and the breast: is adjuvant chemotherapy the right time for a beauty boost? Lessons learned from a large randomized controlled trial.
Qual Life Res
; 31(3): 723-732, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-34324138
16.
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Lancet Oncol
; 22(4): 476-488, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33721561
17.
Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study.
Breast Cancer Res
; 23(1): 9, 2021 01 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33468209
18.
Multicenter evaluation of breast cancer patients' satisfaction and experience with oncology telemedicine visits during the COVID-19 pandemic.
Br J Cancer
; 125(11): 1486-1493, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34588616
19.
Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial.
Oncologist
; 26(8): e1327-e1338, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34028126
20.
Effects of local laser treatment on vulvovaginal atrophy among women with breast cancer: a prospective study with long-term follow-up.
Breast Cancer Res Treat
; 188(2): 501-509, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33891298